Table 5. Seizure freedom in study completers.
| Study phase | N. (%) of patients seizure free | p | |
|---|---|---|---|
| Lamotrigine (n=15) | Topiramate (n=13) | ||
| Dose escalation | 6 (40) | 5 (38) | 1.00 |
| Maintenance | 6 (40) | 6 (46) | 1.00 |
| Entire treatment period | 5 (33) | 4 (31) | 1.00 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.